- Home
- MDGL vs HUBS Comparison
MDGL vs HUBS Comparison
Compare MDGL & HUBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | HUBS |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 12.0B |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MDGL | HUBS |
|---|---|---|
| Price | $429.21 | $238.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 35 |
| Target Price | ★ $685.22 | $253.67 |
| AVG Volume (30 Days) | 273.9K | ★ 812.4K |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 855.56 |
| EPS | N/A | ★ 1.47 |
| Revenue | $180,133,000.00 | ★ $375,612,000.00 |
| Revenue This Year | $59.43 | $17.63 |
| Revenue Next Year | $38.83 | $13.89 |
| P/E Ratio | ★ N/A | $169.65 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $399.00 | $169.63 |
| 52 Week High | $615.00 | $497.96 |
Technical Indicators
Market Signals| Indicator | MDGL | HUBS |
|---|---|---|
| Relative Strength Index (RSI) | 29.53 | 49.69 |
| Support Level | $416.21 | $229.01 |
| Resistance Level | $546.29 | $256.19 |
| Average True Range (ATR) | 16.26 | 11.88 |
| MACD | -1.31 | 0.94 |
| Stochastic Oscillator | 10.31 | 34.46 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About HUBS HubSpot Inc.
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.